AMENDED AND RESTATED TRANSACTION SUPPORT AGREEMENTTransaction Support Agreement • January 10th, 2023 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
This AMENDED AND RESTATED TRANSACTION SUPPORT AGREEMENT (as it may be amended, supplemented or otherwise modified as provided herein, this “Agreement”), initially dated as of December 5, 2022 and amended and restated as of January 9, 2023, is entered into among:
OMNIBUS TRANSACTION AGREEMENTOmnibus Transaction Agreement • January 10th, 2023 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
WHEREAS, pursuant to that certain Transaction Support Agreement, dated as of December 5, 2022 (the “TSA”), among the Issuer, the Convertible Noteholders and the other parties thereto, the Issuer, the Convertible Noteholders and the other parties thereto have agreed to, among other things, consummate the transactions contemplated by the Implementation Steps Memo (as defined in the TSA), either pursuant to the terms thereof or as may be modified pursuant to the terms of the TSA (such Implementation Steps Memo, as may be so modified, the “Implementation Steps Memo”); and
